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Abstract
Background: Maternal diabetes alters gene expression leading to neural tube defects (NTDs) in the developing brain. The
mechanistic pathways that deregulate the gene expression remain unknown. It is hypothesized that exposure of neural
stem cells (NSCs) to high glucose/hyperglycemia results in activation of epigenetic mechanisms which alter gene expression
and cell fate during brain development.
Methods and Findings: NSCs were isolated from normal pregnancy and streptozotocin induced-diabetic pregnancy and
cultured in physiological glucose. In order to examine hyperglycemia induced epigenetic changes in NSCs, chromatin
reorganization, global histone status at lysine 9 residue of histone H3 (acetylation and trimethylation) and global DNA
methylation were examined and found to be altered by hyperglycemia. In NSCs, hyperglycemia increased the expression of
Dcx (Doublecortin) and Pafah1b1 (Platelet activating factor acetyl hydrolase, isoform 1b, subunit 1) proteins concomitant
with decreased expression of four microRNAs (mmu-miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466 d-3p)
predicted to target these genes. Knockdown of specific microRNAs in NSCs resulted in increased expression of Dcx and
Pafah1b1 proteins confirming target prediction and altered NSC fate by increasing the expression of neuronal and glial
lineage markers.
Conclusion/ nterpretation: This study revealed that hyperglycemia alters the epigenetic mechanisms in NSCs, resulting in
altered expression of some development control genes which may form the basis for the NTDs. Since epigenetic changes
are reversible, they may be valuable therapeutic targets in order to improve fetal outcomes in diabetic pregnancy.
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Introduction
Diabetes during pregnancy is a well-known risk factor for
congenital anomalies in various organ systems including the
nervous system [1–3]. Preconceptual control of diabetes has shown
to reduce the incidence of congenital abnormalities in diabetic
mothers [4]. On the other hand a tight glycemic control after
organogenesis and embryogenesis have begun may prove insuffi-
cient to prevent or reverse the congenital defects that have already
occurred [5,6].
Global gene expression profiles of developing brain in embryos
of diabetic mice has shown differential expression of several genes
that control various functions such as metabolism, cellular
physiological process, cell cycle progression and cell migration
during brain development [7]. Neural stem cells (NSCs) are self-
renewing multipotent cells giving rise to neuronal and glial cells
(astrocytes and oligodendrocytes) in the central nervous system [8].
It has been shown that maternal diabetes alters the expression of
several genes involved in neurulation [9,10], proliferation and cell
fate specification [11] of NSCs which may form the basis for
neural tube defects. In the developing brain, NSCs differentiate
into neuronal and glial cell types in a sequential fashion. Cell fate
specification of NSC is determined by extracellular signals,
transcription factors and intracellular programmes such as the
epigenetic regulation of gene expression [12–14]. Recently,
microRNAs (miRNAs) have been shown to be essential in the
post transcriptional control of NSC fate and regulation of gene
expression [13,15].
Dietary changes in methyl donors have shown to alter DNA and
histone methylation [16]. Animal studies have revealed that a
choline -deficient diet during pregnancy results in decreased
methylation in genes that control brain development [17]. It is
therefore evident that the fetal epigenetic mechanisms can be
influenced by maternal nutrition or metabolic disturbances. These
epigenetic changes that are acquired during embryogenesis may
even have long lasting effects on the offspring postnatally [18,19].
It has been shown that high glucose causes persistent alterations in
gene expression in human aortic endothelial cells [20] and human
monocytic cell line [21] through histone modifications. In
addition, excess glucose can increase histone acetylation by
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increasing acetyl CoA in the nucleus [22] suggesting a link
between maternal hyperglycemia and fetal epigenome.
We therefore hypothesize that exposure of NSCs to hypergly-
cemia results in activation of epigenetic mechanisms (chromatin
modification, DNA methylation and miRNA mediated) which
alter the expression of genes during brain development. To
address this, we used NSCs isolated from the forebrain of non-
malformed embryos of streptozotocin induced diabetic pregnancy
and cultured those in medium containing physiological glucose
(PG, 5 mmol/l) concentration to examine epigenetic reprogram-
ming caused in utero by maternal hyperglycemia. First, we
examined the histone and DNA methylation status of NSCs to
determine hyperglycemia induced changes in them. In order to
examine the effect of maternal diabetes on epigenetic regulation of
genes involved in NSC fate specification we selected two genes,
Doublecortin (Dcx), and Platelet activating acetyl hydrolase,
isoform 1b, subunit 1 (Pafah1b1), which are involved in neurogen-
esis and neuronal migration. These genes were selected since their
expression levels were found to be altered in developing brain of
malformed embryos from diabetic pregnancy (in our previous
cDNA microarray analysis) [7]. We identified four miRNAs that
were predicted to target both Dcx and Pafah1b1 and determined if
Dcx and Pafah1b1 were targets of these miRNAs by altering
specific miRNA levels in NSCs. Finally, we examined the role of
each miRNA in NSC fate by differentiating the cells after
knockdown of specific miRNAs in NSCs. We show for the first
time that hyperglycemia alters epigenetic mechanisms in NSCs
which may form the basis for neural tube defects observed in
diabetic pregnancy.
Materials and Methods
Ethics Statement
This study was approved by the National University of
Singapore Institutional Animal Care and Use Committee
(IACUC)(approval number 122\09) and all procedures were in
accordance with its guidelines.
Animals and Culture of NSCs
Diabetes was induced in healthy 6–8 weeks old female Swiss
albino mice (Centre for animal resources, CARE, NUS) by a single
intraperitoneal injection of Streptozotocin (STZ, 75 mg/kg body
weight, Sigma-Aldrich, St. Louis, MO, USA) freshly prepared in
0.01 M citrate buffer pH 4.5. One week later, the blood sugar
levels of the mice were tested using a blood glucose meter (Abbott’s
laboratories, Illinois, USA) and mice with non-fasting glucose
levels of .200 mg/dL were confirmed to be diabetic and selected
for mating. Timed mating was done by placing 3–4 diabetic
female mice with one age matched healthy male mice, in cages
overnight. The day when the copulation plug was seen was
counted as embryonic day 0.5 (E 0.5). Only embryos from
pregnant mice with non-fasting glucose .300 mg/dL were used
as experimental group. Age matched control pregnant mice were
purchased from CARE, NUS. On E13.5, the embryos were
collected by caesarean section of diabetic and control mice that
were anesthetized with pentobarbital (150 mg/kg body weight).
All procedures using laboratory animals were in accordance with
the guidelines of Institutional Animal Care and Use Committee
(IACUC), NUS.
Primary culture of NSCs was obtained from the telencephalon
region of embryonic brains as described previously [11,23].
Briefly, the tissue sections were subjected to mechanical dissoci-
ation in DMEM/F12 (1:1, Invitrogen Life technologies, Carlsbad,
CA, USA) and the cell suspension was filtered through a nylon
mesh (70 mm, BD biosciences, MA, USA). The cells were plated at
a concentration of 10–15 cells/ml [24,25] in DMEM/F12 medium
with 5 mM/L D-Glucose (PG) concentration and supplemented
with insulin-transferrin-selenium supplements (Invitrogen), 20 ng/
ml EGF (Sigma- Aldrich, St. Louis, MO, USA) and an antibiotic
antimycotic solution (Sigma- Aldrich) in T-75 flasks (Corning Life
sciences, Lowell, MA, USA). The cultures were incubated at
37uC/5% CO2 for 5 days after which the supernatant containing
freely floating neurospheres was collected in 50 ml tubes (Greiner
Bio-One GmBH, Germany) and centrifuged at 800 rpm/5 min.
Harvested neurospheres were dissociated with TryPLETM Select
(Gibco, Life technologies, Carlsbad, CA, USA) and re-plated (50–
70 cells/ml) for 3–4 days, during which new neurospheres formed
(Fig. S1 A). Subsequently, a second passage was done (as
previously) and cells were grown for 4–5 days. NSCs were grown
for 12–14 days in total and passaged at least twice before they were
used for experiments. NSCs were stained for expression of
intermediate filamentous marker, Nestin (Fig. S1 B–E). All
neurospheres from embryos of control and diabetic pregnancy
expressed Nestin (Fig. S1 B,C) and all cells within a neurosphere
showed immunoreactivity to Nestin (Fig. S1 D, E).
Exposure of NSCs to High Glucose in vitro
30–50 neurospheres derived from E13.5 embryos of control
pregnancy cultured in PG medium were transferred to 6 well
plates containing 2 ml medium with high glucose concentration
(HG, 40 mM/L D-glucose) and cultured for 48 h.
Differentiation of Neurospheres
5–10 neurospheres derived from E13.5 embryos of control or
diabetic pregnancy was plated per well of a 24 well plate
containing poly-ornithine coated coverslips. Each well contained
500 ml of medium with PG concentration and 2% FBS (and no
EGF) in order to induce differentiation. The NSCs were allowed
to differentiate for 3 days or 6 days in vitro after which the
percentages of Gfap, Map2 or Ng2 positive cells were estimated by
immunostaining.
Immunostaining
For immunostaining, the neurospheres or differentiated cells
were fixed with ice cold 4% paraformaldehyde (PFA) for 30 min
and the fixed cells were permeabilized with phosphate buffered
saline (PBS) containing 0.1% Triton-X 100 (PBS-Tx) for 20 min.
Subsequently, the cells were blocked with 5% normal goat serum
for 30 min before incubation with the different primary antibod-
ies. The primary antibodies used were rabbit anti-Gfap antibody
(1:500, Chemicon, Temecula, CA, USA) or rabbit anti-Map2
antibody (1:500, Chemicon) or rabbit anti-Ng2 antibody (1:200
Chemicon) or mouse anti-Nestin antibody (1:500, Millipore, USA)
overnight at 4uC. The next day, cells were incubated with Cy3-
conjugated goat anti-rabbit IgG secondary antibody (1:100,
chemicon) or rabbit anti-mouse IgG secondary antibody (1:100
Chemicon) for 1 h at room temperature. Finally, the nucleus was
counterstained with DAPI and the coverslips were mounted on
glass slides with fluorescent mounting medium (DAKO, USA).
Images were captured with Olympus FV1000 confocal micro-
scope. For estimating the percentage of Map2 or Gfap or Ng2
positive cells, confocal images from at least five random fields were
captured for each sample. The number of positive cells (Map2 or
Gfap or Ng2) was counted in each field and data was represented
as percentage of positive cells (Map2 or Gfap or Ng2) relative to
the total number of cells in that field.
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Electron Microscopy
NSCs from various groups were harvested by centrifugation
(800 rpm/5 min/4uC) and washed twice with PBS, after which
the cells were fixed (2% PFA, 3% glutaraldehyde in PBS) for
1 h at room temperature. The fixed cells were harvested by
centrifugation, washed thrice with PBS and incubated in PBS
solution overnight at 4uC. The cells were then post fixed in 1%
OsO4, pH 7.4 for 2 h at room temperature after which they
were washed with 0.1 M phosphate buffer (pH 7.4). The cells
were then dehydrated through an ascending ethanol series at
room temperature and infiltrated with 100% acetone: resin (1:6)
overnight at room temperature. After three changes in resin, the
cells were embedded in fresh resin and polymerized at 55uC for
1 h. Sections cut were supported on grids (150 nm) and the
slides were stained with uranyl acetate (10 min) and lead citrate
(8 min) at room temperature. Images were captured using Bio
Twin CM 120 (Philips) electron microscope.
Histone Protein Extraction and Assays
Total histone proteins were isolated from NSCs from various
groups using EpiQuik total histone extraction kit (Epigentek,
Farmingdale, NY) following the manufacturers’ instruction.
Histone extracts (2 mg) from each sample was used to quantify
Histone H3K9 trimethylation or acetylation using EpiQuik Global
trimethyl histone H3K9 quantification kit (Epigentek, Farming-
dale, NY) or EpiQuik Global acetyl histone H3K9 quantification
kit (Epigentek) following the manufacturers’ protocol.
DNA Isolation
Genomic DNA was extracted from NSCs from various groups
using DNeasy blood and tissue kit (Qiagen, Hilden, Germany).
The extracted DNA was quantitated using Nanodrop spectropho-
tometer.
Global DNA Methylation Quantification
Genomic DNA (200 ng) from each NSC group was used to
quantify the global DNA methylation levels using Methylamp
global DNA methylation quantification kit (Epigentek, Farming-
dale, NY) and the manufacturer’s instructions were followed. All
samples were analyzed in duplicate. A standard curve was plotted
using the methylated DNA control supplied in the kit and the
DNA methylation % was calculated based on the standard curve.
RNA Isolation
Total RNA was extracted from the control and experimental
groups using mirVanaTM kit (Ambion, Carlsbard, CA, USA)
according to the manufacturer’s protocol. The isolated RNA was
used for miRNA analysis or mRNA qRT-PCR.
cDNA Synthesis and mRNA Analysis
Reverse transcription was done using 2 mg RNA and 2 ml
oligodT, 200 U of molony murine leukemia virus (M-MLV)
reverse transcriptase, 5 U of RNasin (Promega, Madison, WI,
USA), 2 mmol/L of each dNTPs, in a 25 ml reaction volume. The
mRNA expression was quantified by real time RT-PCR analysis
carried out in Applied Biosystems (Applied Biosystems, Foster city,
CA, USA) 7900 HT instrument using 10 ml master mix containing
5 ml SYBR green (Qiagen, Hilden, Germany), 1 mM/L of each
primer (Table 1), 1 ml cDNA and Nuclease free water in 96 well
FAST optical plates. The fold change of mRNA expression was
calculated by 22DDCt method [26].
Protein Isolation and Western Blotting
Protein was extracted from the NSCs using the mammalian
protein extraction reagent (M-PER, Thermo scientific, Rock-
ford, IL USA) following the manufacturer’s protocol. The
extracted protein was quantitated using the Bradford method
(Bio-Rad, Hercules, CA, USA). 20 mg of protein from each
sample was denatured at 95uC for 5 min and separated on a
10% SDS-PAGE. The proteins were transferred to PVDF
membranes and blocked with 5% non-fat milk for 1 h at room
temperature. The blots were incubated in primary antibody,
rabbit anti-Dcx antibody (1:1000, Abcam, Cambridge, MA) or
rabbit anti-Pafah1b1 antibody (1:1000, Abcam, Cambridge,
MA) or mouse anti-beta actin antibody (1:5000, Sigma, St.
Loius, MO,USA) overnight at 4uC. The blots were then
incubated with secondary anti-mouse or anti-rabbit HRP
conjugated antibody (Pierce, Rockford, IL, USA) for 1 h at
room temperature. The blots were developed with enhanced
chemiluminescence reagent (Pierce, Rockford, IL, USA) and
quantitated on densitometer (Bio-Rad, Hercules, CA, USA)
using Quantity One software (Bio-rad, Hercules, CA, USA).
Equal protein loading was confirmed by stripping and re-
probing the blots with beta actin antibody.
Bisulphite Sequencing and Cloning
DNA (1 mg) from each NSC group was bisulfite treated and
purified using Epitect bisulfite kit (Qiagen, Hilden, Germany),
following the manufacturer’s protocol. Bisulfite specific primers
were designed using Methylprimer Express softwareV1.0 (Ap-
plied Biosystems, Foster City, CA, USA) spanning 350–400 bp
of CpG islands in the gene promoter. The bisulfite treated
DNA was then amplified by PCR and the PCR amplicons were
purified and subcloned into the TOPO TAR cloning kit
(Invitrogen, Life technologies, Carlsbad, CA, USA). Plasmid
DNA was isolated from 6 positive colonies and sequenced. The
eletropherograms were analyzed using the BiQ analyzer
software (Max-Planck Institut fur Informatik, Germany) and
the methylation pattern was represented as lollipop grids. Open
circles represent unmethylated CpG sites and closed (shaded)
circles represent methylated CpG sites. The primer sequences
used for PCR and sequencing are listed in Table S1 in Tables
S1.
miRNA Target Prediction
We used the miRWalk database (http://www.ma.uni-
heidelberg.de/appa/zmf/mirwalk/) to predict miRNA-mRNA
interactions in the 39UTR of the genes under study. The results
of the search are summarized in Table 2.
In situ Hybridization
NSCs from normal pregnancy were transferred into 24 well
plates with poly lysine coated coverslips and the cells were
allowed to adhere for 48 h. 59 Fluorescein labelled miRCURY
LNA TM probes were purchased for mouse U6, mmu-miR-200b
and mmu-miR-466d-3p from Exiqon (Vedbaek, Denmark)(Ta-
ble S2 in Tables S1). We followed a previously published
protocol for in situ hybridization [27]. Briefly, the cells were
fixed with 4% PFA, permeabilized with 0.1% PBS-Tx, and
acetylated with acetylation solution containing acetic anhydride
and triethanolamine. The probes were denatured and then
allowed to hybridize to cells overnight at a temperature ranging
from 55uC to 60uC (that was 22uC less than the melting
temperature of the probe). Post hybridization washes were done
at 75uC to 80uC (that was 20uC greater than hybridization
Hyperglycemia Alters Epigenetic Mechanisms
PLOS ONE | www.plosone.org 3 June 2013 | Volume 8 | Issue 6 | e65945
temperature). The NSCs were counterstained with DAPI (1 mg/
ml, Molecular probes) and coverslips were mounted on glass
slides with fluorescent mounting medium (DAKO). Images were
captured with Olympus FV1000 confocal microscope.
miRNA Analysis
Mouse miRNA primers mmu-miR-200a, mmu-miR-200b,
mmu-miR-466a-3p mmu-miR- 466d-3p, were purchased from
Applied Biosystems Foster City, CA, USA (Taqman TM miRNA
Real time assay) and control primer set snoRNA234 was used to
normalize the samples. Total RNA was reverse transcribed using
miRNA specific stem-loop RT primers and subsequently the
expression of miRNA was detected using specific miRNA primers.
Mouse mmu-miR-124 and control U6 primers were purchased
from Exiqon (Vedbaek, Denmark). Total RNA was converted to
cDNA using the Universal cDNA synthesis kit (Exiqon, Vedbaek,
Denmark) and the cDNA was used for quantification of miRNA-
124.The miRNA expression was quantified by real time RT-PCR
analysis using 96 well FAST optical plates (7900 HT, Applied
Biosystems). The fold change in miRNA expression was calculated
by 22DDCt method [26].
miRNA Knock Down
NSCs from normal pregnancy cultured in medium containing
PG concentration were used for miRNA knockdown. Just before
transfection, the NSCs were trypsinised gently to yield single
cells and 26105 cells were seeded per well of a 24 well plate.
Transfection was done using X-tremeGENE siRNA transfection
reagent (Roche Applied Sciences, Mannheim, Germany) follow-
ing the manufacturer’s instruction. 59flourescently labelled
miRCURY LNA TM miRNA inhibitors mmu-miR-200b,
mmu-miR-466d-3p, and non labeled miRCURY LNA TM
mmu-miR-200a, mmu-miR-466a-3p and were purchased from
Exiqon (Vedbaek, Denmark) (Table S3 in Tables S1). Trans-
fection complexes were prepared in opti-MEM medium
(Invitrogen, Life technologies, Carlsbad, CA, USA) and added
to the cells at final concentration of 20 nM/L. 59 fluorescently
labeled scrambled probe was used as the negative control. 48 h
post transfection, protein expression of the predicted mRNA
targets was analyzed by Western blot.
miRNA Knockdown and Lineage Specification of NSCs
For lineage specification, the NSCs were harvested by
centrifugation 48 h after knockdown with miRNA inhibitors
and trypsinised to yield single cells. About 10,000 cells from
scrambled or miRNA knockdown wells were plated in triplicate
(one each for Gfap, Map2 and Ng2) in 24 well plates containing
poly-ornithine (Sigma-Aldrich, St. Louis, MO, USA) coated
coverslips. In order to induce differentiation, EGF was
withdrawn from the culture medium and 2% FBS was added
to the medium and cells were cultured for 24 h before
proceeding with immunostaining using glial and neuronal cell
lineage markers. For estimating percentage of cells, confocal
images from at least five random fields were captured for each
slide. The percentage of Gfap, Ng2 and Map2 positive cells
were calculated in miRNA knockdown cells and normalized to
scrambled transfected cells.
Statistical Analysis
Data is represented as mean 6 SD from at least three
independent experiments. Student’s t test was done by using
Microsoft Excel spreadsheet and data was considered significant
when p,0.05.
Table 1. Primers used for mRNA qRT-PCR.
Gene name Forward Primer(59 –39) Reverse primer(59- 39) Product size
Dcx TCCAGTCAGCAAAGGTAAGGA CCAAGAGAGAACAGCAAACCA 146 bp
Pafah1b1 GATGACAAGACCCTCCGTGT GAGCTCAAATGGGGTAACCA 240 bp
Map2 CTGGACATCAGCCTCACTCA AATAGGTGCCCTGTGACCTG 164 bp
Gfap AGAAAACCGCATCACCATTC TCACATCACCACGTCCTTGT 184 bp
Ng2 GCACGATGACTCTGAGACCA AGCATCGCTGAAGGCTACAT 223 bp
Beta actin GAAGAGCTATGAGCTGCCTGA GGATTCCATACCCAAGAAGGA 103 bp
doi:10.1371/journal.pone.0065945.t001
Table 2. miRNA and mRNA target prediction by miRWalk.
mRNA miRNA
No. of databases
predicting interaction Names of databases
Dcx mmu-miR-200a 6 DIANAmT, miRanda, miRDB, miRWalk, PITA, Targetscan
mmu-miR-200b 6 DIANAmT, miRanda, miRWalk, PITA, Targetscan, PICTAR 4
mmu-miR-466a-3p 4 miRanda, miRWalk, PITA, Targetscan
mmu-miR-466d-3p 4 miRanda, miRWalk, PITA, Targetscan
Pafah1b1 mmu-miR-200a 4 DIANAmT, miRanda, PITA, Targetscan
mmu-miR-200b 5 .DIANAmT, miRanda, miRWalk, PITA, Targetscan
mmu-miR-466a-3p 4 miRanda, miRWalk, PITA, Targetscan
mmu-miR-466d-3p 4 miRanda, miRWalk, PITA, Targetscan
doi:10.1371/journal.pone.0065945.t002
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Results
Chromatin Reorganization in NSCs Exposed to
Hyperglycemia
In this study, NSCs were isolated from embryos of normal
pregnancy and diabetic pregnancy and cultured in medium with
PG. In addition, NSCs derived from embryos of normal
pregnancy were cultured in medium with high glucose (HG) for
48 h so as to serve as in vitro model of diabetic pregnancy. The
effect of hyperglycemia on chromatin organization in nuclei of
NSCs was analyzed using transmission electron microscopy as it
was hypothesized that hyperglycemia could trigger chromatin
modifications in NSCs. Heterochromatin clumps were found to be
increased (indicated as dark, dense regions) at the nuclear
periphery of NSCs from diabetic pregnancy (Fig. 1C) and that
exposed to HG in vitro (Fig. 1B) when compared to the control
(Fig. 1A) suggesting that hyperglycemia triggers the reorganization
of chromatin in embryonic NSCs. This also provides evidence that
the chromatin reorganization observed in NSCs from embryos of
diabetic pregnancy was indeed the effect of hyperglycemia as
similar results were obtained when NSCs (derived from normal
pregnancy) were cultured in HG in vitro.
Increased Global Histone H3K9 Trimethylation and DNA
Methylation and Decreased Histone H3K9 Acetylation in
NSCs Exposed to Hyperglycemia
The chromatin consists of DNA that can be methylated and
histone proteins that undergo modifications which control
chromatin packaging and organization [28]. Hence we postulated
that the chromatin reorganization observed in NSCs exposed to
hyperglycemia is associated with histone modifications or DNA
modifications. Therefore we analyzed the status of histone H3
lysine 9 (trimethylation and acetylation) and DNA methylation
levels in NSCs. The status of histone modifications was examined
by an ELISA based approach using two histone antibodies: anti-
trimethyl histone H3 lysine 9 (H3K9me3) and anti-acetyl histone
H3 lysine 9 (H3K9ac). The reason for selection of these two
antibodies was because H3K9me3 is generally associated with
transcriptional silencing, whereas H3K9ac is associated with
transcriptional activation [29]. Interestingly, NSCs from diabetic
pregnancy (130.42620.41%, p,0.05) and that exposed to HG
in vitro (125.4867.98%, p,0.05) showed a significant increase in
transcriptional silencing, when compared to the control
(90.6065.01%)(Fig. 1D). In addition, NSCs from diabetic
pregnancy (72.6363.79%, p,0.05) and that exposed to HG
in vitro (78.3464.05%, p,0.05) showed a significant decrease in
transcriptional activation when compared to the control
(90.1367.31%)(Fig. 1E). Further, we examined the effect of
hyperglycemia on global DNA methylation using an ELISA based
approach. We found that the percentage of DNA methylation in
NSCs from diabetic pregnancy (0.4560.02%, p,0.05) and that
exposed to HG in vitro (0.4960.04%, p,0.05) was significantly
increased when compared to the control (0.3660.06%) (Fig. 1F).
Epigenetic Regulation of Genes Involved in
Neurogenesis, Neuronal Migration in NSCs Exposed to
Hyperglycemia
We have previously demonstrated that maternal diabetes
perturbed neurogenesis and neuronal migration in the developing
neural tube resulting in NTDs [7]. To examine if the altered gene
expression was due to changes in epigenetic mechanisms, we
selected two genes namely, Dcx and Pafah1b1 that are involved in
neurogenesis and neuronal migration. The expression of Dcx and
Pafah1b1 mRNA and protein in NSCs from control and diabetic
pregnancy were analyzed by qRT-PCR (Fig. 2A) and Western blot
(Figs. 2B,C). The expression of Dcx (4.7961.99 vs 1.0060.13-
folds, p,0.05) and Pafah1b1 (2.5560.93 vs 1.0460.33-folds,
p,0.05) mRNAs were significantly increased in NSCs from
diabetic pregnancy when compared to the control (Fig. 2A). In
addition, the quantities of Dcx (2.8661.93 vs 1.0060.60-folds,
p,0.05) and Pafah1b1 (3.0560.88 vs 1.0060.51-folds, p,0.05)
proteins increased significantly in NSCs from diabetic pregnancy
when compared to the control (Fig. 2C). Further, the mRNA
expression of Dcx (1.7360.35 vs 1.0860.47-folds, p,0.05) and
Pafah1b1 (1.3660.16 vs 1.0060.06-folds, p,0.05) increased
significantly in NSCs exposed to HG in vitro when compared to
the control (Fig. 2D). In order to identify if the changes in mRNA
expression in NSCs exposed to hyperglycemia (in vivo and in vitro)
were due to changes in CpG methylation, we performed bisulphite
conversion followed by cloning and sequencing of isolated DNA.
There was no change in CpG methylation at Pafah1b1 gene
promoter in NSCs from diabetic pregnancy or that exposed to HG
in vitro when compared to the control (Fig. S2). CpG islands were
found to be absent in the promoter of Dcx gene.
Subsequently, the percentages of neuronal and glial cells were
estimated since hyperglycemia increased the expression of Dcx
and Pafah1b1. The neurospheres of control and diabetic
pregnancy were allowed to differentiate in medium with PG and
2% FBS, without EGF for 3 days or 6 days in vitro and the
neuronal and glial populations were identified by immunostaining
with Map2 (Microtubule associated protein 2) or Gfap (Glial
fibrillary acidic protein) or Ng2 (neuron-glial antigen 2) or Nestin
(Fig. 2E–L and Fig. S3 A–H) and quantified. The percentages of
neuronal and glial positive cells were estimated after 3 and 6 days
of differentiation in order to check if prolonged differentiation
would alter the neurogenesis: gliogenesis ratio. All the differenti-
ated cells from NSCs of control and diabetic pregnancy showed
immunoreactivity to Nestin (Fig. 2 K,L, and Fig. S3 G,H). The
percentage of Map2 positive cells increased significantly at 3 days
(37.5564.64 vs 28.4165.30%, p,0.05) and 6 days (43.6364.57 vs
30.1765.71%, p,0.05) post differentiation. However, the per-
centages of Gfap positive cells at 3 days (44.19610.97 vs
77.0464.53%, p,0.05) and 6 days (45.4764.72 vs
75.5263.10%, p,0.05) and Ng2 positive cells at 3 days
(5.0561.00 vs 8.8061.08%, p,0.05) and 6 days (4.1460.73 vs
9.4360.96%, p,0.05) decreased significantly in differentiated cells
from NSCs of diabetic pregnancy when compared to the control
signifying that hyperglycemia increased neurogenesis and de-
creased gliogenesis (Fig. 2M).
Hyperglycemia Alters the Expression of miRNAs in NSCs
miRNAs predicted to target the 39 UTR of selected genes (Dcx
and Pafah1b1) were identified from miRWalk database [30].
Among several miRNAs predicted to target proposed genes, we
analyzed four miRNAs from two families (Table 2) that were
common targets to selected genes. We performed in situ
hybridization of two representative miRNAs (mmu-miR-200b
and mmu-miR-466d-3p) selected from each family of miRNA that
are investigated in this study (mmu-miR-200 and mmu-miR-466
family) in unbiased manner to detect whether these miRNAs were
expressed by NSCs. Both mmu-miR-200b and mmu-miR-466d-
3p were found to be expressed by NSCs (Figs. 3A,B). Having
confirmed that these miRNAs were expressed in NSCs we then
sought to quantitate their expression levels by real time RT-PCR
in NSCs. The expression levels of miRNA mmu-miR-200a
(0.00960.009 vs 1.0660.45-folds, p,0.05), mmu-miR-200b
(0.02160.02 vs 1.0460.37-folds, p,0.05), mmu-miR-466a-3p
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(0.05460.01 vs1.0160.21-folds, p,0.05) and mmu-miR-466d-3p
(0.02860.02 vs 1.0160.21-folds, p,0.01) were significantly
decreased in NSCs from diabetic pregnancy when compared to
the control (Fig. 3C). In NSCs from diabetic pregnancy, the
significant increase in protein expression of Dcx and Pafah1b1
correlates well with the reduced expression of miRNAs (mmu-
miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-
466d-3p) (Figs. 2B and 3C) which have been predicted to target
Dcx and Pafah1b1 suggesting possible role for miRNA in
regulating gene expression.
Since hyperglycemia increased neurogenesis in NSCs, we
analyzed the expression of miR-124, which has been widely
shown to promote neurogenesis [31]. The expression of mmu-
miR-124 was increased significantly in NSCs from diabetic
pregnancy (8.8362.77 vs 1.0060.40-folds, p,0.05) when com-
pared to the control (Fig. 3D). The increased expression of miR-
124 correlated with increased neurogenesis in NSCs from diabetic
pregnancy (Figs. 3D and 2M).
miRNA-mRNA Target Validation Confirms Target
Prediction
We performed miRNA loss of function study in order to validate
the predicted miRNA-mRNA interactions, since the expression of
selected miRNAs was significantly downregulated in NSCs from
diabetic pregnancy. Individual miRNAs were knocked down in
NSCs isolated from normal pregnancy using miRCURY LNA TM
Figure 1. Hyperglycemia alters epigenetic mechanisms in NSCs. (A–C) Representative transmission electron microscopy images of NSCs from
control (A), that exposed to high glucose (HG) in vitro (B) and from diabetic pregnancy (C). Increased heterochromatin structure at the nuclear
periphery was observed in NSCs exposed to HG and that from diabetic pregnancy (white arrows). Bar represents 1 mm. (magnification: 13,500). (D, E)
The percentage of H3K9me3 (D) was significantly increased in NSCs exposed to HG in vitro (black bars) and that from diabetic pregnancy (open bars)
when compared to the control (grey bars) while the percentage of H3K9ac (E) was significantly decreased in NSCs exposed to HG in vitro (black bars)
and that from diabetic pregnancy (open bars) when compared to the control (grey bars). (F) Increased percentage of DNA methylation was observed
in NSCs exposed to HG in vitro (black bars) and that from diabetic pregnancy (open bars) when compared to the control (grey bars). The bar
represents the mean 6 SD of at least 4 independent experiments, *p,0.05.
doi:10.1371/journal.pone.0065945.g001
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Figure 2. Increased Dcx and Pafah1b1 expression and increased neurogenesis in NSCs from diabetic pregnancy. (A) mRNA expression
of Dcx and Pafah1b1 increased significantly in NSCs from diabetic pregnancy (open bars) compared to the control (filled bars). (B, C) The expression
and quantities of Dcx and Pafah1b1 proteins in NSCs from control and diabetic pregnancy were estimated by Western blot. (B) Representative blot
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miR inhibitors. The expression of the target proteins (Dcx and
Pafah1b1) were analyzed by western blotting 48 h post miRNA
knockdown (Fig. 4A). Knockdown of miRNAs, mmu-miR-200a,
or mmu-miR-200b, or mmu-miR-466a-3p or mmu-miR-466d-3p
resulted in increased expression of Dcx (1.7860.57-folds, p,0.05;
1.4260.34-folds, p,0.05; 2.1260.40-folds, p,0.05; 2.9861.05-
folds, p,0.05 respectively) (Fig. 4B) and Pafah1b1 (1.9360.43-
folds, p,0.05; 1.6960.57-folds, p,0.05; 1.6460.45-folds, p,0.05;
1.6860.34-folds, p,0.01 respectively) (Fig. 4C) proteins in NSCs.
miRNA Knockdown Increases Gliogenesis and
Neurogenesis in NSCs
Given that we observed increased expression of proteins
involved in neurogenesis, and neuronal migration after knock-
down of miRNAs in NSCs, we examined the role of these miRNAs
in NSC fate determination. miRNAs, mmu-miR-200a, mmu-miR-
200b, mmu-miR-466a-3p and mmu-miR-466d-3p were knocked
down individually in NSCs in culture. Following knockdown of
miRNAs, differentiation was induced and the neuronal and glial
lineage populations were estimated by immunocytochemical
analysis.
There was significantly increased astrogenesis as indicated by
increased Gfap positive cells following knockdown of miRNAs,
mmu-miR-200a (120.5266.54%, p,0.01) or mmu-miR-200b
(11562.24%, p,0.01) or mmu-miR-466a-3p (126.53618.87%,
p,0.05) compared to scrambled (Scr) transfected cells (Fig. 5 A–E,
i). Similarly, the knockdown of miRNA mmu-miR-200b
(128.09610.46%, p,0.05) or mmu-miR-466d (116.0566.19%,
p,0.05) increased the number of Ng2 positive cells when
compared to scrambled transfected cells (Fig. 5F–J,ii). Knockdown
of only mmu-miR-200a (135.25619.34%, p,0.05) or mmu-miR-
466a-3p (121.54617.29%, p,0.05) significantly increased the
number of Map2 positive cells compared to scrambled transfected
cells (Fig. 5K–O, iii), signifying increased neurogenesis.
Discussion
Maternal diabetes has been shown to alter the expression of
genes involved in neurogenesis, neuronal migration, and differen-
tiation of NSCs, leading to neural tube defects [7,11]. However,
the exact mechanism behind the deregulation of genes leading to
brain defects is not clear. It has long been argued that epigenetic
mechanisms are involved in modulating the expression patterns of
multiple genes that are implicated in impaired neurodevelopment
in offspring of diabetic pregnancy. Although the management of
diabetes during pregnancy has reduced the occurrence of
congenital malformations greatly, infants of diabetic mothers have
been shown to develop neuropsychological deficits [32]. Analyzing
phenotypically normal embryos may be essential in understanding
the molecular details behind the occurrence of neuropsychological
deficits in offspring of diabetic mothers. The present study clearly
shows that hyperglycemia activates epigenetic mechanisms that
result in altered gene expression in NSCs derived from diabetic
pregnancy and cultured in PG medium.
shows the expression of Dcx and Pafah1b1 proteins in NSCs from embryos of control and diabetic pregnancy. (C) The quantities of Dcx and Pafah1b1
proteins increased significantly in NSCs from embryos of diabetic pregnancy (open bars) compared to the control (filled bars). (D) Dcx and Pafah1b1
mRNA increased significantly in NSCs exposed to HG in vitro (filled bars) when compared to the control (open bars). (E–L) Neurospheres from
embryos of control and diabetic pregnancy were allowed to differentiate for 3 days in vitro and the expression of neuronal (Map2), glial (Gfap, Ng2),
and Nestin positive cell populations were determined by immunocytochemistry. (M) The percentage of Map2 positive cells was significantly
increased while the percentages of Gfap and Ng2 positive cells were significantly reduced in NSCs from diabetic pregnancy (open bars) on both 3
days or 6 days post differentiation when compared to the control(closed bars). Data is represented as mean 6 SD from at least four independent
experiments, *p,0.05.
doi:10.1371/journal.pone.0065945.g002
Figure 3. miRNA expression is altered in NSCs from diabetic
pregnancy. (A, B) in situ hybridization reveals expression of miRNAs
mmu-miR-200b (A) and mmu-miR-466d-3p (B) in NSCs. The nucleus is
counterstained with DAPI (blue). Scale bar: 50 mm. (C) miRNA
expression analysis revealed decreased expression of miRNAs mmu-
miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466d-3p
in NSCs from diabetic pregnancy (open bars) when compared to the
control (filled bars). Mean 6 SD (n = 4), *p,0.05, **p,0.01 (D)
Expression of neuron specific miRNA, miR-124 was significantly
increased in NSCs from diabetic pregnancy (open bars) when compared
to the control (filled bars). Data is represented as mean6 SD from three
independent experiments, *p,0.05.
doi:10.1371/journal.pone.0065945.g003
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Chromatin packaging is controlled by reversible histone
modifications and DNA methylation patterns and determines
accessibility and availability of DNA for transcription via specific
acetylation or methylation marks on histone. Heterochromatin
regions that regulate gene expression by adding or removing
silencing marks to genes [33], are known to present at the nuclear
periphery [34] as revealed in TEM analysis. Among the histone
lysine methylation, H3K9me3 residue has been shown to be
associated with gene promoters that are transcriptionally repressed
and is most abundant in heterochromatin regions [35]. High
Figure 4. miRNA loss of function confirms Dcx and Pafah1b1 as targets. (A) Representative Western blot showing Dcx and Pafah1b1 protein
expression after knockdown of specific miRNAs in NSCs. (B,C) The quantities of Dcx (B) and Pafah1b1 (C) proteins increased significantly in NSCs
following knockdown of mmu-miR-200a or mmu-miR-200b or mmu-miR-466a-3p or mmu-miR-466d-3p when compared to scrambled (scr)
transfected cells. Data is represented as mean 6 SD from at least four independent experiments, *p,0.05. **p,0.01.
doi:10.1371/journal.pone.0065945.g004
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glucose has been reported to alter gene expression by acetylation
or methylation of lysine residues on histone H3 [20,21]. Taken
together, the increased global H3K9me3 and decreased H3K9ac
observed in NSCs from diabetic pregnancy and NSCs exposed to
HG in vitro indicate that histone modifying enzymes are possibly
activated by hyperglycemia, resulting in altered gene expression.
Further, global methylation assay revealed increased DNA
methylation in NSCs from diabetic pregnancy and NSCs exposed
to HG in vitro. The increased DNA methylation may be
responsible for aberrant gene expression (possibly due to DNA
hypermethylation at gene promoters) in NSCs from diabetic
pregnancy and NSCs exposed to HG in vitro. Although global
DNA methylation levels were found to be increased, upregulation
of Pafah1b1 gene expression in NSCs from diabetic pregnancy
and NSCs exposed to HG in vitro was not due to changes in CpG
methylation.
Neurogenesis and neuronal migration are key events controlling
proper development of the brain. Defective neurogenesis or
neuronal migration results in brain abnormalities [36,37]. In order
to understand the role of hyperglycemia on fate specification of
NSCs, we have analyzed expression of two genes (Dcx and
Pafah1b1) involved in neurogenesis and neuronal migration [37–
39]. Both Dcx and Pafah1b1 were found to be significantly altered
in the brain tissue of embryos from diabetic mice by our previous
microarray studies. Dcx is expressed by migrating neuronal
precursors [40] and functions upstream to Pafah1b1 gene during
neuronal migration [41]. Further, Pafah1b1 is required for
accurate orientation of spindle (and therefore proliferation) in
neuroepithelial stem cells and radial glial progenitor cells [42].
Upregulation or downregulation of Pafah1b1 or Dcx have been
shown to affect brain development. Decreased expression of Dcx
and/or Pafah1b1 contributes to Lissencephaly that is character-
ized by ‘‘smooth brain appearance’’ [43]. Increased expression of
Dcx inhibits proliferation and promotes migration of human
neural progenitors [44]. Increased expression of Pafah1b1 has
been shown to affect brain development including size and cellular
organization in humans and mice [45]. In the present study, an
increased expression of Dcx, Pafah1b1 proteins in the NSCs from
diabetic pregnancy appear to be associated with increased
neurogenesis. It appears that hyperglycemia promotes neurogen-
esis at the cost of gliogenesis since the expression levels of Gfap and
Ng2, markers of astrocytes and oligodendrocytes respectively, were
found to be decreased in NSCs from diabetic pregnancy. The
decreased expression of glial markers in NSCs exposed to
hyperglycemia could also be due to the fact that the gliogenesis
has been shown to be preceded by the neurogenesis in the
developing cortex [46]. Although there was no change in the
differentiation pattern in NSCs from embryos of control and
diabetic pregnancy at different time points (3 days and 6 days of
differentiation), the possibility of delayed gliogenesis cannot be
excluded since NSCs were isolated from only one embryonic stage
(E113.5) in this study. Overall, it is suggested that hyperglycemia
perturbed the cell fate choice between neurons and glia. It is not
clear what drives the hyperglycemia-induced glia–neuron switch,
although several genes appear to be involved.
It is well known that miRNAs regulate gene expression via
binding to 39UTR sequences causing repression or degradation of
the target mRNAs. miR-200 family has been reported to regulate
olfactory neurogenesis in mouse and zebrafish models [47] and the
expression of few members of miR-466 family have been shown in
mouse ocular tissue [48]. This study is the first to report the
expression of miRNAs mmu-miR-200a, mmu-miR-200b, mmu-
miR-466a-3p and mmu-miR-466 d-3p in NSCs obtained from
mouse embryonic forebrain. Further, we confirmed that Dcx and
Pafah1b1 were targets of miRNAs mmu-miR-200a, mmu-miR-
200b, and mmu-miR-466a-3p and mmu-miR-466d-3p by using
knockdown approach. miR-124 is expressed abundantly in the
mouse brain [49], specifically in the neurons and its expression is
found to increase during development [50–52]. Several studies
have demonstrated the role of miR-124 in promoting neurogenesis
and neuronal differentiation [52–55]. In the present study,
increased neurogenesis observed correlated with increased expres-
sion of neuron specific miRNA, miR-124.
Recently miRNAs have been shown to promote and regulate
cell lineage specification in mouse and human cells [56]. Since
knockdown of specific miRNAs increased the expression of
proteins involved in neurogenesis and neuronal migration, we
examined their roles in NSC fate determination. We report novel
role of miRNAs mmu-miR-200a, mmu-miR-200b, mmu-miR-
466a-3p and mmu-miR-466d-3p in regulating neurogenesis and
gliogenesis in vitro by targeting and upregulating Gfap, Map2 and
Ng2 proteins either through direct target or through an indirect
regulation which needs detailed evaluation. Since each of the
miRNAs are reported to contain hundreds of mRNA targets
(miRwalk database), it is possible that many targets are involved in
this complex process of NSC fate determination. Altered NSC fate
due to differential miRNA expression induced by hyperglycemia
may explain the basis for patterning defects observed in the
developing brain exposed to maternal diabetes.
In conclusion, this study demonstrates that epigenetic mecha-
nisms are activated in NSCs by hyperglycemia, resulting in
chromatin reorganization, altered histone H3K9 status, increased
global DNA methylation, and altered miRNA expression thereby
promoting increased expression of neuronal and glial lineage
markers. This study is clinically relevant owing to the fact that
epigenetic changes are persistent even when NSCs from diabetic
pregnancy were cultured in normoglycemia and NSCs from non-
malformed embryos are sensitive to glucotoxicity suggesting that
phenotypically normal embryos are genotypically distinct and
deficient. Since epigenetic changes are reversible, using them as
therapeutic targets may improve fetal outcomes in diabetic
pregnancy.
Supporting Information
Figure S1 (A) Phase contrast image of Neural stem cells
(NSCs) in culture, as free floating neurospheres. Scale
bar: 150 mm. (B–E) Confocal images of neurosphere stained with
intermediate filament marker Nestin in red. DAPI is used to stain
the nucleus blue. (B, C) All neurospheres obtained from control (B)
or diabetic pregnancy (C) express immunoreactivity to Nestin. (D,
E) Panel shows the expression of Nestin by all cells within a
Figure 5. miRNAs regulate NSC fate. The effect of miRNA knockdown on NSC fate was assayed. Specific miRNAs were knocked down in NSCs and
the percentage of Gfap, Ng2 or Map2 positive cells were quantitated in differentiated cells. Confocal images showing the expression of Gfap positive
cells (A–E), Ng2 positive cells (F–J) and Map2 positive cells (K–O) (red) in differentiated cells following knockdown of miRNAs mmu-miR-200a or mmu-
miR-200b or mmu-miR-466a-3p or mmu-miR-466d-3p in NSCs. Quantitative analysis shows the percentage of Gfap positive cells (i), Ng2 positive cells
(ii) and Map2 positive cells (iii) following knockdown of specific miRNAs. Data is represented as mean 6 SD from at least three independent
experiments, *p,0.05. **p,0.01.
doi:10.1371/journal.pone.0065945.g005
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neurosphere from embryos of control (D) or diabetic pregnancy
(E).
(TIFF)
Figure S2 Bisulphite sequencing of DNA from NSCs
from control, diabetic pregnancy and that exposed to
HG in vitro was performed and methylation pattern was
represented as lollipop grid. There was no change in CpG
methylation status at Pafah1b1 promoter in NSCs from diabetic
pregnancy or that exposed to HG in vitro when compared to the
control. Data from six clones is represented here where each row
represents the sequencing information received from a single clone
across 27 CpG sites (2310 to 246). Open circles represent
unmethylated CpG sites and closed (shaded) circles represent
methylated CpG sites.
(TIFF)
Figure S3 (A–H) Neurospheres from embryos of control
and diabetic pregnancy were allowed to differentiate for
six days in vitro and the expression of neuronal (Map2),
glial (Gfap, Ng2), and Nestin positive cell populations
were determined by immunocytochemistry.
(TIFF)
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